Safraz Hamid

About

Dr. Safraz Hamid is a leading figure in metabolic and bariatric surgery, with a focused expertise in comparing the efficacy and safety of modern surgical techniques for obesity and metabolic disease. His most impactful work, "Outcomes of SADI and OAGB Compared to RYGB from the Metabolic and Bariatric Surgery Quality Improvement Program: The North American Experience" (2024), represents a landmark contribution to the field. By leveraging the vast, multi-institutional MBSAQIP database, Dr. Hamid provides a rigorous, real-world analysis of single-anastomosis duodeno-ileal bypass (SADI) and one-anastomosis gastric bypass (OAGB) against the gold-standard Roux-en-Y gastric bypass (RYGB). This study, already garnering early citations, offers critical comparative outcomes on complications, weight loss, and comorbidity resolution, directly informing surgical decision-making and patient counseling. Dr. Hamid’s work is instrumental in shaping evidence-based practice, helping surgeons and patients navigate the expanding landscape of bariatric procedures. His research exemplifies the power of large-scale data to drive clinical insights, solidifying his reputation as a key contributor to advancing safer and more effective metabolic surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Outcomes of SADI and OAGB Compared to RYGB from the Metabolic and Bariatric Surgery Quality Improvement Program: The North American Experience

   2 citations · 2024

Key Collaborators

Contact & Links